Oxford Biomedica plc

OXB.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£60,650£103,716£141,285£108,944
Short-Term Investments£0£0£23£74
Receivables£42,113£13,342£57,595£42,095
Inventory£13,573£12,872£12,625£9,521
Other Curr. Assets£16,858£11,399£3,976£3,210
Total Curr. Assets£133,194£141,329£215,504£163,844
Property Plant & Equip (Net)£64,296£75,692£133,780£69,728
Goodwill£0£0£661£0
Intangibles£29,219£30,981£105,225£52
Long-Term Investments£4,934£4,340£5,010£3,605
Tax Assets£0£0-£5,010-£3,605
Other NC Assets£0£0£5,010£3,605
Total NC Assets£98,449£111,013£244,676£73,385
Other Assets£0£0£0£0
Total Assets£231,643£252,342£460,180£237,229
Liabilities
Payables£9,612£6,052£13,604£5,260
Short-Term Debt£4,420£7,308£6,590£1,706
Tax Payable£0£1,478£2,347£1,899
Deferred Revenue£0£0£19,264£13,396
Other Curr. Liab.£44,289£29,477£17,858£11,046
Total Curr. Liab.£58,321£44,315£59,663£33,307
LT Debt£104,341£107,804£110,986£8,488
Deferred Rev, NC£1,070£5,331£1,145£1,852
Deferred Tax Liab, NC£0£0£5,588£0
Other NC Liab.£7,424£17,058£46,606£6,244
Total NC Liab.£112,835£130,193£164,325£16,584
Other Liabilities£0£0£0£0
Cap. Leases£68,690£72,924£74,501£9,341
Total Liabilities£171,156£174,508£223,988£49,891
Equity
Pref Stock£0£0£27,178£0
Common Stock£52,981£48,403£48,132£43,088
Retained Earnings-£399,500-£352,918-£198,545-£165,806
AOCI£8,709-£1,812-£27,178£2,291
Other Equity£394,856£380,333£355,066£307,765
Total Equity£57,046£74,006£204,653£187,338
Supplemental Information
Minority Interest£3,441£3,828£31,539£0
Total Liab. & Tot. Equity£231,643£252,342£460,180£237,229
Net Debt£48,111£11,396-£23,709-£98,750
Oxford Biomedica plc (OXB.L) Financial Statements & Key Stats | AlphaPilot